Allergan Inc. plans to build a laboratory on its Irvine campus to make small quantities of neurotoxin, a component used in its flagship anti-wrinkle drug Botox.
The drug maker plans to keep production of Botox, which is used in several medical and cosmetic treatments, at its Westport, Ireland plant, said Caroline Van Hove, a company spokeswoman.
Allergan will ship the neurotoxin to the Irish plant as needed to make Botox, a purified form of the botulinum toxin.
The 30,000-square-foot lab is set to be built next to Allergan’s primary research and development facility, the Herbert Research Center. The lab is expected to open in 2007.
Van Hove declined to say how many workers would be at the laboratory. Allergan has some 1,100 research and development scientists worldwide, but is reluctant to give totals for OC.
For more on this story, see the July 17 issue of the Business Journal.
